Cell Cycle Regulation of IRP2 Phosphorylation During Hematopoiesis
造血过程中 IRP2 磷酸化的细胞周期调控
基本信息
- 批准号:10639952
- 负责人:
- 金额:$ 55.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated RegionsAffectAlanineAllelesAnemiaBindingBinding ProteinsBlood Cell CountBone MarrowBone Marrow CellsBone Marrow TransplantationCRISPR/Cas technologyCell CycleCell Cycle ArrestCell Cycle RegulationCell DeathCell Differentiation processCell LineageCell SurvivalCellsCharacteristicsCodon NucleotidesDNA biosynthesisDevelopmentDuodenumDysmyelopoietic SyndromesElementsEmbryoEngineeringEnterobacteria phage P1 Cre recombinaseEnterocytesErythroblastsErythrocytesErythroidErythroid CellsErythropoiesisExhibitsFerritinFibroblastsFlow CytometryFunctional disorderG2 PhaseGene ExpressionGenerationsGoalsHela CellsHematological DiseaseHematologyHematopoiesisHematopoietic stem cellsHemeHemoglobinIn VitroInheritedIronIron Regulatory Protein 2Knock-in MouseLoxP-flanked alleleMacrocytic AnemiaMediatingMessenger RNAMitochondriaMitosisMolecularMouse StrainsMusMutateOxidative StressOxygenPathway interactionsPersonsPhenotypePhosphorylationPhysiologicalPopulationProcessProductionProliferatingProteinsProteomicsRNARNA BindingReportingRespirationRoleS phaseSKP Cullin F-Box Protein LigasesSerineSerumSpleenSplenomegalySupporting CellSystemTFRC geneTestingTissuesTranslationsTransplantationcell growthcell growth regulationcofactorerythroid differentiationin vivoinsightiron deficiencyiron metabolismmRNA StabilitymRNA Translationmetal transporting protein 1mouse modelmutantnovelposttranscriptionalsingle-cell RNA sequencingstemstem cell proliferationtransplant modelubiquitin ligaseuptake
项目摘要
ABSTRACT
Iron is essential for cellular growth due to its role as a cofactor in proteins involved in DNA synthesis,
mitochondrial respiration and hemoglobin production. Vertebrate iron metabolism is controlled post-
transcriptionally by iron-regulatory protein 2 (Irp2). Irp2 binds to iron-responsive elements (IREs) in the mRNAs
of proteins involved in iron uptake (transferrin receptor 1), sequestration (ferritin) and export (ferroportin), and
regulates the translation or stability of these mRNAs. During iron deficiency, Irp2 binds IREs to regulate mRNA
translation or stability, whereas during iron sufficiency, Irp2 is degraded by the FBXL5-SCF ubiquitin ligase.
Here we show that Irp2 is regulated by iron-independent phosphorylation of Ser157 during G2/M that disrupts
its interaction with ferritin IRE mRNA during mitosis and depresses ferritin translation. Expression of Irp2-S157A
in Irp2KO-MEFs causes a G2/M delay and slows proliferation. The significance of S157 phosphorylation was
investigated in mice where Ser157 was mutated to Ala157 (Irp2A/A)). Irp2A/A mice exhibit macrocytic anemia,
defective erythroid terminal differentiation, splenomegaly, and dysregulated systemic iron metabolism. We
propose that cell-cycle regulation of ferritin and other IRE-mRNAs may provide a mechanism to modulate the
cellular labile iron pool during the cell cycle. Our overall goal is to determine how loss of S157 phosphorylation
perturbs erythropoiesis and causes anemia. Our aims are to 1) determine the cell-autonomous role for Irp2-
S157 phosphorylation in erythropoiesis by bone marrow (BM) transplantation and flow cytometric analysis of
cell-cycle status, proliferation, iron and other parameters, 2) identify mechanisms underlying dysregulated
erythropoiesis in Irp2A/A mice using a mouse erythroblast in vitro differentiation system with WT and Irp2A/A BM
cells, and proteomic analysis of erythroblast populations to identify protein changes between WT and Irp2A/A
cells, and 3) generate an erythroid-specific Irp2A/A knockin mouse model to study erythroid terminal
differentiation. We anticipate that our studies will provide new insights of normal and dysregulated
erythropoiesis.
抽象的
铁对于细胞生长至关重要,因为它是参与 DNA 合成的蛋白质的辅助因子,
线粒体呼吸和血红蛋白产生。脊椎动物的铁代谢在后期受到控制
由铁调节蛋白 2 (Irp2) 转录。 Irp2 与 mRNA 中的铁反应元件 (IRE) 结合
参与铁摄取(转铁蛋白受体 1)、隔离(铁蛋白)和输出(铁转运蛋白)的蛋白质,以及
调节这些 mRNA 的翻译或稳定性。缺铁期间,Irp2 结合 IRE 来调节 mRNA
翻译或稳定性,而在铁充足期间,Irp2 被 FBXL5-SCF 泛素连接酶降解。
在这里,我们表明 Irp2 在 G2/M 期间受到与铁无关的 Ser157 磷酸化的调节,从而破坏
它在有丝分裂过程中与铁蛋白 IRE mRNA 相互作用并抑制铁蛋白翻译。 Irp2-S157A的表达
Irp2KO-MEF 中的 Irp2KO-MEF 会导致 G2/M 延迟并减慢增殖。 S157磷酸化的意义是
在 Ser157 突变为 Ala157 (Irp2A/A) 的小鼠中进行了研究。 Irp2A/A小鼠表现出大细胞性贫血,
红系终末分化缺陷、脾肿大和全身铁代谢失调。我们
提出铁蛋白和其他 IRE-mRNA 的细胞周期调节可能提供一种调节机制
细胞周期期间细胞不稳定的铁库。我们的总体目标是确定 S157 磷酸化的丧失是如何发生的
干扰红细胞生成并导致贫血。我们的目标是 1) 确定 Irp2 的细胞自主作用-
骨髓 (BM) 移植红细胞生成中的 S157 磷酸化和流式细胞术分析
细胞周期状态、增殖、铁和其他参数,2) 确定失调的机制
使用具有 WT 和 Irp2A/A BM 的小鼠成红细胞体外分化系统在 Irp2A/A 小鼠中进行红细胞生成
细胞和成红细胞群体的蛋白质组学分析,以确定 WT 和 Irp2A/A 之间的蛋白质变化
细胞,3) 生成红细胞特异性 Irp2A/A 敲入小鼠模型来研究红细胞末端
差异化。我们预计我们的研究将为正常和失调提供新的见解
红细胞生成。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth Ann Leibold其他文献
Elizabeth Ann Leibold的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth Ann Leibold', 18)}}的其他基金
NOVEL BIOCHEMICAL ROLES FOR IRON REGULATORY PROTEIN 2
铁调节蛋白 2 的新生化作用
- 批准号:
7007329 - 财政年份:2005
- 资助金额:
$ 55.5万 - 项目类别:
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 55.5万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 55.5万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 55.5万 - 项目类别:
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
IL-17A mRNA 靶向寡核苷酸治疗特发性肺纤维化 (IPF)
- 批准号:
10761365 - 财政年份:2023
- 资助金额:
$ 55.5万 - 项目类别:
miR-342, a novel glucocorticoid-responsive miRNA necessary for Foxp3+ regulatory T cell function
miR-342,一种新的糖皮质激素反应性 miRNA,是 Foxp3 调节 T 细胞功能所必需的
- 批准号:
10671943 - 财政年份:2023
- 资助金额:
$ 55.5万 - 项目类别: